Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder

Histopathology. 1993 Apr;22(4):327-33. doi: 10.1111/j.1365-2559.1993.tb00131.x.

Abstract

Expression of c-erbB-2 protein, neuron-specific enolase (NSE) and DNA ploidy was studied by immunohistochemistry and flow cytometry in formalin-fixed and paraffin-embedded specimens from 104 patients with locally advanced transitional cell carcinoma of the bladder. Positive membrane bound c-erbB-2 staining was found in 15% of the tumours, and 38% of the tumours were positive for NSE. Only one tumour stained positively for both NSE and c-erbB-2. Expression of c-erbB-2 protein and NSE was neither correlated to tumour stage nor to histopathological grade. The frequency of non-diploid tumours was 78% in 49 c-erbB-2/NSE negative tumours, 98% in 40 NSE positive tumours, and 100% in 16 c-erbB-2 positive tumours (P = 0.004). Whether the c-erbB-2 expression is a useful prognostic marker in addition to other conventional parameters, remains to be shown.

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Transitional Cell / genetics
  • Carcinoma, Transitional Cell / metabolism
  • Carcinoma, Transitional Cell / pathology*
  • Carcinoma, Transitional Cell / therapy
  • Combined Modality Therapy
  • DNA, Neoplasm / analysis*
  • Flow Cytometry
  • Humans
  • Immunoenzyme Techniques
  • Phosphopyruvate Hydratase / analysis*
  • Ploidies
  • Proto-Oncogene Proteins / analysis*
  • Receptor, ErbB-2
  • Urinary Bladder Neoplasms / genetics
  • Urinary Bladder Neoplasms / metabolism
  • Urinary Bladder Neoplasms / pathology*
  • Urinary Bladder Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Proto-Oncogene Proteins
  • Receptor, ErbB-2
  • Phosphopyruvate Hydratase